It is thus speculated that the upregulation of GALR3 in DLBCL may indirectly affect immune cell functions and immune factor secretion through the nervous system, alter the tumor microenvironment, and influence the disease progression of DLBCL. Here, GALR3 is linked to diffuse large B-cell lymphoma.